<DOC>
	<DOCNO>NCT00234962</DOCNO>
	<brief_summary>The purpose study evaluate effect adherence HIV antiviral response treatment regimens contain Kaletra HIV protease inhibitor .</brief_summary>
	<brief_title>Study Adherence Effects Clinical Outcomes Kaletra Based HIV Antiviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>Subject document HIV positive Subject great equal 18 year age . Subject currently regimen either NNRTI + 2 Nucleoside Reverse Transcriptase Inhibitors NRTIs ) , two three NRTIs fail regimen evidence two consecutive viral load value 1,000 copies/mL , last one within last three month , Na√Øve subject ARV regimen require begin PI contain HAART regimen , Subjects become intolerant current antiretroviral regimen require change first time PI contain HAART regimen . Subject laboratory test within previous three month recent test demonstrate follow : Hemoglobin &gt; 8.0 g/dL ; Absolute neutrophil count &gt; 750 cells/mL ; Platelet count &gt; 20,000/mL ; ALT AST &lt; 3 x Upper Limit Normal ( ULN ) ; Creatinine &lt; 1.5 x ULN ; Triglycerides &lt; 750 mg/dL . Subjects evidence grade III IV adverse event laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>HIV Infection</keyword>
	<keyword>HAART</keyword>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>